In diabetic nephropathy, downregulation of SETD6 protects podocytes from apoptosis and mitochondrial dysfunction induced by high glucose and palmitic acid by activating the Nrf2-Keap1 signaling pathway [29]. This evidence concerns the gene SETD6 and diabetic kidney disease.